Forging a position as an innovative player in
infectious disease vaccines and therapies
Home
About
Company Overview
Board and management
News
Our Technology
Technology and Products
LAIV
BDM-I
About Our Disease Targets
Business Development
Partner Network
Licensing Strategy and Available Licenses
Investor Relations
Announcements
Financial Reports
Share trading
Videos
Corporate governance
Newsletters
Media
Contact Us
Corporate directory
BioDiem
» » Company Update and EOFY 2018 Information
Company Update and EOFY 2018 Information
August 3, 2018 •
Category
•
Author Name
View the announcement here
Latest News
2022 BioDiem Annual Report
November 25, 2022
View the Annual Report
Read More
Exercise of Options
October 1, 2022
Read the announcement
Read More
